Newsroom | 50914 results

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE) for clinical decision making, today announced a scientific, multi-layered process for content review for novel evidence studies in Alexandria, the Atropos Evidence Library. The review process establishes the standard for the healthcare industry with a rigorous methodology for the vetting of novel evidence studies, ensuring that the evidence produced...

TORONTO & LEESBURG, Fla.--(BUSINESS WIRE)--Greenspace Health and LifeStream Behavioral Center, a leading nonprofit provider of behavioral health and social services in Central Florida, have partnered to implement Measurement-Based Care (MBC) across LifeStream’s full continuum of programs. The collaboration will leverage data-driven insights and patient-reported outcome measures (PROMs) within the care process to improve service quality and clinical outcomes for thousands of individuals served a...

LOS ANGELES--(BUSINESS WIRE)--Sutter Health is expanding the use of FloPatch, the first wireless, wearable Doppler ultrasound device, across three additional Northern California hospitals: Sutter Solano Medical Center in Vallejo, Sutter’s Mills-Peninsula Medical Center in Burlingame and the Berkeley campus of Sutter’s Alta Bates Summit Medical Center, as part of its ongoing effort to enhance personalized intravenous (IV) fluid management for patients with sepsis and other life-threatening condi...

EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in CNS drug and device development, today announced it has successfully completed an inspection by the U.S. Food and Drug Administration (FDA) with no observations. This outcome underscores Clinilabs continued commitment to the highest standards of regulatory compliance, operational excellence, and patient safety across its clinical research programs. “Each FDA...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Antiva reports Phase 1b/2 data showing ABI-2280 clears high-risk HPV with strong efficacy, durability, and safety vs placebo....

Lausanne, Suisse--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), société biopharmaceutique indépendante basée en Suisse dont la vocation est de mettre au point les traitements de référence de demain afin de guérir le cancer et les maladies infectieuses, présentera de nouvelles données révolutionnaires lors du congrès annuel 2026 de l’American Association for Cancer Research (AACR) à San Diego, en Californie. L’un des temps forts de la participation au congrès de cette année sera la première...

LAUSANNE, Switzerland--(BUSINESS WIRE)--Debiopharm presents new DDR, dual‑payload ADC and AI biomarker research at AACR 2026, including first clinical data from the MYTHIC study....

CAMARILLO, Calif.--(BUSINESS WIRE)--Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and designed to work throughout the body to target the tumor microenvironment, a key driver of treatment resistance and immune evasion. The treatment, a novel transdermal therapy designed to modulate tumor pH, helped make tumors substantially less acidic, restore T-cell activity, slow tumor...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the acceptance of one oral presentation and two poster presentations at the ATS International Conference in Orlando, Florida, May 17-20, 2026. Oral Presentation Title: Molgramostim Improves Exercise Distance and Duration in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP): Results from the IMPALA-2 Phase 3 Clinical Trial Mini Sympo...

CAMPBELL, Calif.--(BUSINESS WIRE)--Atia Vision Announces Durable 36-Month Results from First-in-Human Study of their Dynamic Shape-Changing OmniVu Intraocular Lens System...